Novel pandemic flu vaccine effective against H5N1 in mice

Mar 01, 2009

Vaccines against H5N1 influenza will be critical in countering a possible future pandemic. Yet public health experts agree that the current method of growing seasonal influenza vaccines in chicken eggs is slow and inefficient.

Scientists at the Emory Vaccine Center have developed an alternative: virus-like particles, empty shells that look like viruses but don't replicate. Mice immunized by nose drops with the virus-like particles (VLPs) were protected for months against an otherwise lethal H5N1 infection.

The results are described in the March issue of PLoS ONE (Public Library of Science ONE).

"These results suggest that VLPs could form the basis of an effective human vaccine against H5N1 influenza," says senior author Richard Compans, PhD, professor of microbiology and immunology at Emory University School of Medicine.

Several worldwide influenza outbreaks have occurred during the past century, with the worst being the Spanish Flu of 1918, which killed more than 50 million people.

The H5N1 variant of influenza, found among birds in Asia in the 1990s, has killed the majority of the several hundred people known to have been infected with it. Public health officials fear that H5N1, to which the human population has not developed immunity, could evolve to be transmissible between humans and cause a global pandemic with very high mortality.

Making influenza vaccines in chicken eggs poses several disadvantages. Producing vaccines takes months. Making enough for millions of people could severely stress the world's vaccine-making capacity, especially since the poultry industry would probably be crippled in a pandemic. In addition, work with live H5N1 virus is dangerous and should only be performed in special laboratories.

As an alternative to live influenza viruses, VLPs are made by introducing three separate viral genes into baculoviruses, which only infect insect cells. Baculovirus-infected insect cells are then grown in culture, in a similar fashion to bacteria or yeast, and produce the VLPs. The VLPs appear to have a structure like influenza viruses under an electron microscope but lack the ability to replicate or to cause influenza.

Compans and first author Sang-Moo Kang, PhD, Emory assistant professor of microbiology and immunology, demonstrated the ability of VLPs to stimulate antibody production in mice. In collaboration with a team at the Centers for Disease Control and Prevention led by Ruben Donis, PhD, they showed that the mice immunized with VLPs could resist an otherwise lethal dose of H5N1 virus isolated from Vietnam.

The mice's immunity, including the levels of antibodies that protected their respiratory systems, stayed stable for over six months.

In mice, VLPs appear to deliver several times more potency per microgram than other types of vaccines, such as the chemically inactivated subunit viral vaccine currently used in the United States or a single viral protein produced in baculovirus.

"This extra potency is important because the current egg-grown vaccines require relatively high doses to be effective for most people, and in a pandemic demand might run up against production capacity. VLPs could offer more bang for the buck," Compans says.

Some next steps in the development of the vaccine are to find out if it can also protect against infection by mutant forms of the virus that arise frequently in birds, he says. Also, the vaccine will be evaluated in other animal species, in which influenza causes disease symptoms similar to those seen in humans.

More information: SM Kang et al. Induction of Long-term Protective Immune Responses by Influenza H5N1 Virus-Like Particles. PLOS ONE (2009). dx.plos.org/10.1371/journal.pone.0004667

Source: Emory University

Explore further: Newly discovered hormone mimics the effects of exercise

add to favorites email to friend print save as pdf

Related Stories

Cool crystals and hot climates

Jan 16, 2015

A crystalline structure used by a silkworm virus to protect itself from the elements may provide similar protection for human vaccines in challenging tropical climates and remote regions.

How did the chicken beat the infection?

Dec 23, 2014

A new Emmy Noether Group in LMU's Faculty of Veterinary Science is dedicated to understanding the mechanisms that underlie the operation of the immune system in chickens.

Recommended for you

Newly discovered hormone mimics the effects of exercise

3 hours ago

Scientists at the USC Leonard Davis School of Gerontology have discovered a new hormone that fights the weight gain caused by a high-fat Western diet and normalizes the metabolism - effects commonly associated ...

Highly sensitive detection of malaria parasites

5 hours ago

New assays can detect malaria parasites in human blood at very low levels and might be helpful in the campaign to eradicate malaria, reports a study published this week in PLOS Medicine. An international team l ...

How fat breakdown contributes to insulin resistance

11 hours ago

New research from the University of Virginia School of Medicine has shed light on how chronic stress and obesity may contribute to type 2 diabetes. The findings point the finger at an unexpected biological perpetrator – ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.